{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:18:08Z","timestamp":1784729888294,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In January 2023, British Columbia (BC), Canada, piloted a three-year decriminalization policy to address the escalating overdose crisis. The policy seeks to reduce stigma and the fear of criminal prosecution, and foster a safer and more supportive environment, encouraging greater utilization of treatment and harm reduction (HR) services among people who use drugs. There are limited data on the operational characteristics of HR sites in BC, which are essential for monitoring how decriminalization may influence service operations and utilization. This study aimed to characterize HR site operations in BC and assess any operational changes following decriminalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional, online self-report survey was distributed to HR sites across BC between March and April 2024. The survey was completed by a site representative, and survey questions focused on client demographics and drug use patterns, service uptake and capacity, resource and staffing demands, police activity near sites, and the availability of HR services. Changes pre-and post-decriminalization were analyzed descriptively to identify trends.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 33\u00a0HR sites completed the survey. Almost a third (30%) of sites reported an increase in client\u2019s post-decriminalization, and 18% indicated plans to expand or modify services to meet the increasing demand. However, challenges related to staffing and resources were highlighted, with 45% of sites reporting increased staffing demands post-decriminalization, and 33% noting changes to resource needs, most of which increased. Five sites reported an increase in annual operating budgets. Nearly half (43%) of sites that experienced police activity around their site reported increased police activity post-decriminalization. Moreover, approximately one-fifth (21%) of sites received formal decriminalization training.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HR sites have experienced an increase in client engagement post-decriminalization, reporting challenges related to site capacity and funding, and emphasizing the need for additional investments to support and expand HR services. Consideration should be given to needs-based planning and providing decriminalization training to HR staff. Moreover, steps are necessary to address the continued police presence near sites, which may hinder service uptake and perpetuate stigma. Addressing these gaps is critical for improving health system engagement for people who use drugs and achieving the goals of decriminalization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01276-y","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:19:21Z","timestamp":1752837561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey"],"prefix":"10.1186","volume":"22","author":[{"given":"Farihah","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juls","family":"Budau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Patenaude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"1276_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.","journal-title":"Harm Reduct J"},{"key":"1276_CR2","unstructured":"Canadian Mental Health Association Ontario. Harm Reduction Toronto, ON: Canadian Mental Health Association Ontario. 2024 [Available from: https:\/\/ontario.cmha.ca\/harm-reduction\/"},{"key":"1276_CR3","doi-asserted-by":"crossref","unstructured":"Dow-Fleisner SJ, Lomness A, Woolgar L. Impact of safe consumption facilities on individual and community outcomes: A scoping review of the past decade of research. Emerging Trends in Drugs, Addictions, and Health. 2022;2.","DOI":"10.1016\/j.etdah.2022.100046"},{"issue":"1","key":"1276_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","volume":"21","author":"MA Andresen","year":"2010","unstructured":"Andresen MA, Boyd N. A cost-benefit and cost-effectiveness analysis of vancouver\u2019s supervised injection facility. Int J Drug Policy. 2010;21(1):70\u20136.","journal-title":"Int J Drug Policy"},{"key":"1276_CR5","volume-title":"Perceptions of safe injection sites","author":"Pollara Strategic Insights","year":"2023","unstructured":"Pollara Strategic Insights. Perceptions of safe injection sites. Toronto, ON: Pollara Strategic Insights; 2023."},{"key":"1276_CR6","volume-title":"Vancouver\u2019s INSITE service and other supervised injection sites: what has been learned from research? - Final report of the expert advisory committee on supervised injection site research [Health Canada, 2008]","author":"Health Canada","year":"2008","unstructured":"Health Canada. Vancouver\u2019s INSITE service and other supervised injection sites: what has been learned from research? - Final report of the expert advisory committee on supervised injection site research [Health Canada, 2008]. Ottawa, ON: Health Canada; 2008."},{"issue":"5","key":"1276_CR7","doi-asserted-by":"publisher","first-page":"e0251860","DOI":"10.1371\/journal.pone.0251860","volume":"16","author":"TC Wild","year":"2021","unstructured":"Wild TC, Koziel J, Anderson-Baron J, Asbridge M, Belle-Isle L, Dell C, et al. Public support for harm reduction: A population survey of Canadian adults. PLoS ONE. 2021;16(5):e0251860.","journal-title":"PLoS ONE"},{"key":"1276_CR8","volume-title":"B.C.\u2018s toxic drug crisis: implementation of harm reduction programs","author":"MA Pickup","year":"2024","unstructured":"Pickup MA. B.C.\u2018s toxic drug crisis: implementation of harm reduction programs. Victoria, BC: Office of the Auditor General of British Columbia; 2024."},{"issue":"1","key":"1276_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13011-024-00625-7","volume":"19","author":"KA Urbanoski","year":"2024","unstructured":"Urbanoski KA, van Roode T, Selfridge M, Hogan KC, Fraser J, Lock K, et al. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British columbia, Canada. Subst Abuse Treat Prev Policy. 2024;19(1):44.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1276_CR10","doi-asserted-by":"publisher","first-page":"e076336","DOI":"10.1136\/bmj-2023-076336","volume":"384","author":"A Slaunwhite","year":"2024","unstructured":"Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B, et al. Effect of risk mitigation guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. 2024;384:e076336.","journal-title":"BMJ"},{"key":"1276_CR11","unstructured":"Vancouver Coastal Health. Supervised Consumption & Overdose Prevention Sites Vancouver, BC: Vancouver Coastal Health. 2023 [Available from: https:\/\/www.vch.ca\/en\/service\/supervised-consumption-overdose-prevention-sites#find-it-near-you"},{"issue":"5","key":"1276_CR12","doi-asserted-by":"publisher","first-page":"e0229208","DOI":"10.1371\/journal.pone.0229208","volume":"15","author":"B Pauly","year":"2020","unstructured":"Pauly B, Wallace B, Pagan F, Phillips J, Wilson M, Hobbs H, et al. Impact of overdose prevention sites during a public health emergency in victoria, Canada. PLoS ONE. 2020;15(5):e0229208.","journal-title":"PLoS ONE"},{"key":"1276_CR13","unstructured":"Health Canada. Supervised consumption sites - Dashboard. August 22. 2024 ed. Ottawa, Canada: Government of Canada; 2024."},{"issue":"5","key":"1276_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"1276_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1503\/cmaj.080808","volume":"179","author":"AM Bayoumi","year":"2008","unstructured":"Bayoumi AM, Zaric GS. The cost-effectiveness of vancouver\u2019s supervised injection facility. CMAJ. 2008;179(11):1143\u201351.","journal-title":"CMAJ"},{"key":"1276_CR16","unstructured":"BC HelpStartsHere. Rapid Access Addiction Clinics (RAACs) 2024 [Available from: https:\/\/helpstartshere.gov.bc.ca\/resource\/rapid-access-addiction-clinics-raacs"},{"key":"1276_CR17","unstructured":"BC Mental Health & Substance Use Services. BC Mental Health & Substance Use Services 2024 [Available from: https:\/\/www.bcmhsus.ca\/"},{"key":"1276_CR18","volume-title":"Rapid access models for substance use services: A rapid review","author":"B Rush","year":"2020","unstructured":"Rush B, Furlong A. Rapid access models for substance use services: A rapid review. Ottawa, ON: Canadian Centre on Substance Use and Addiction; 2020."},{"key":"1276_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7517-3-24","volume":"3","author":"E Drucker","year":"2006","unstructured":"Drucker E, Insite. Canada\u2019s landmark safe injecting program at risk. Harm Reduct J. 2006;3:24.","journal-title":"Harm Reduct J"},{"key":"1276_CR20","volume-title":"Core services Model - A component of British columbia\u2019s substance use framework","author":"B Appendix","year":"2022","unstructured":"BC Ministry of Mental Health and Addictions, Appendix B. Core services Model - A component of British columbia\u2019s substance use framework. Vancouver, BC: BC Ministry of Mental Health and Addictions; 2022."},{"key":"1276_CR21","volume-title":"More than 130 experts in substance use call on federal government to continue to support and Scale-up safer supply programs [press release]","author":"Letter","year":"2023","unstructured":"Letter. More than 130 experts in substance use call on federal government to continue to support and Scale-up safer supply programs [press release]. Toronto, ON: HIV Legal Network; 2023."},{"issue":"1","key":"1276_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13011-018-0158-1","volume":"13","author":"E Jozaghi","year":"2018","unstructured":"Jozaghi E, Greer AM, Lampkin H, Buxton JA. Activism and scientific research: 20 years of community action by the Vancouver area network of drug users. Subst Abuse Treat Prev Policy. 2018;13(1):18.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1276_CR23","unstructured":"BC Centre for Disease Control (BCCDC). Unregulated drug poisoning emergency dashboard. October 16, 2023. BCCDC; 2024."},{"key":"1276_CR24","unstructured":"BC Coroners Service. Unregulated Drug Deaths 2023. In: Coroner OotC, editor. Victoria, BC2023."},{"key":"1276_CR25","doi-asserted-by":"crossref","unstructured":"Russell C, Law J, Bonn M, Rehm J, Ali F. The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions. Int J Drug Policy. 2023;111(2023):103933.","DOI":"10.1016\/j.drugpo.2022.103933"},{"key":"1276_CR26","volume-title":"Social and structural contexts of the overdose crisis: an ethnography of overdose risk among structurally vulnerable women who use drugs in vancouver, Canada","author":"AB Collins","year":"2020","unstructured":"Collins AB. Social and structural contexts of the overdose crisis: an ethnography of overdose risk among structurally vulnerable women who use drugs in vancouver, Canada. Vancouver, BC: Simon Fraser University; 2020."},{"key":"1276_CR27","unstructured":"Todd D. Why has Europe been spared Canada\u2019s fentanyl disaster? Vancouver Sun 2023."},{"key":"1276_CR28","unstructured":"(UNODC) UNOoDaC. Understanding the global opioid crisis. United Nations OFfice on Drugs and Crime (UNODC); 2019."},{"issue":"1","key":"1276_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. They look at Us like junkies: influences of drug Use stigma on the healthcare engagement of people who inject drugs in new York City. Harm Reduct J. 2020;17(1):53.","journal-title":"Harm Reduct J"},{"key":"1276_CR30","doi-asserted-by":"crossref","unstructured":"Greene C, Urbanik M, Geldart R. Experiences with compounding surveillance and social control as a barrier to safe consumption service access. SSM - Qualitative Res Health. 2022;2.","DOI":"10.1016\/j.ssmqr.2022.100055"},{"key":"1276_CR31","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.drugpo.2020.102991","volume":"88","author":"MM Urbanik","year":"2021","unstructured":"Urbanik MM, Greene C. Operational and contextual barriers to accessing supervised consumption services in two Canadian cities. Int J Drug Policy. 2021;88:102991.","journal-title":"Int J Drug Policy"},{"key":"1276_CR32","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.drugpo.2019.102618","volume":"76","author":"S Goldenberg","year":"2020","unstructured":"Goldenberg S, Watt S, Braschel M, Hayashi K, Moreheart S, Shannon K. Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: results of a community-based cohort in metro vancouver, Canada. Int J Drug Policy. 2020;76:102618.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1276_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-019-0302-x","volume":"16","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, Strike C, Altenberg J, Barnaby L, Kerr T. Implementation contexts and the impact of policing on access to supervised consumption services in toronto, canada: a qualitative comparative analysis. Harm Reduct J. 2019;16(1):30.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1276_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2012.06.008","volume":"24","author":"L Ti","year":"2013","unstructured":"Ti L, Wood E, Shannon K, Feng C, Kerr T. Police confrontations among street-involved youth in a Canadian setting. Int J Drug Policy. 2013;24(1):46\u201351.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1276_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.drugpo.2007.08.004","volume":"19","author":"D Werb","year":"2008","unstructured":"Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, et al. Effects of Police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy. 2008;19(4):332\u20138.","journal-title":"Int J Drug Policy"},{"key":"1276_CR36","volume-title":"Takes action to save lives, build new connections of care with drug decriminalization [press release]","author":"B.C","year":"2023","unstructured":"B.C. Takes action to save lives, build new connections of care with drug decriminalization [press release]. Vancouver, BC: Government of British Columbia; 2023."},{"key":"1276_CR37","unstructured":"Province of British Columbia. Decriminalizing people who use drugs in B.C. Vancouver, BC: Province of British Columbia. 2024 [Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/overdose\/decriminalization"},{"issue":"1","key":"1276_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12889-024-17845-y","volume":"24","author":"A Greer","year":"2024","unstructured":"Greer A, Xavier J, Loewen OK, Kinniburgh B, Crabtree A. Awareness and knowledge of drug decriminalization among people who use drugs in British columbia: a multi-method pre-implementation study. BMC Public Health. 2024;24(1):407.","journal-title":"BMC Public Health"},{"key":"1276_CR39","unstructured":"Toward the Heart. Toward the Heart 2024 [Available from: https:\/\/towardtheheart.com\/site-finder"},{"key":"1276_CR40","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"key":"1276_CR41","unstructured":"Statistics Canada. Index of Remoteness. 2021. Ottawa, ON: Statistics Canada; 2023."},{"key":"1276_CR42","volume-title":"Developing meaningful categories for distinguishing levels of remoteness in Canada","author":"R Subedi","year":"2020","unstructured":"Subedi R, Rohsanafshar S, Greenberg TL. Developing meaningful categories for distinguishing levels of remoteness in Canada. Ottawa, ON: Statistics Canada; 2020."},{"key":"1276_CR43","unstructured":"HealthMatch BC. BC Health Authorities Map 2024 [Available from: https:\/\/pcnjobsbc.ca\/?da_image=258"},{"key":"1276_CR44","volume-title":"Decriminalization data report to health canada: February 2023-January 2024","author":"Ministry of Mental Health and Addictions","year":"2024","unstructured":"Ministry of Mental Health and Addictions. Decriminalization data report to health canada: February 2023-January 2024. Vancouver, BC: BC Ministry of Mental Health and Addictions; 2024."},{"issue":"7","key":"1276_CR45","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s10461-022-03957-2","volume":"27","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shannon K, Buxton JA, Ti L, Genovy TA, Braschel M, et al. Precarious housing associated with unsuppressed viral load, sub-optimal access to HIV treatment and unmet health care needs, among women living with HIV in metro vancouver, Canada. AIDS Behav. 2023;27(7):2271\u201384.","journal-title":"AIDS Behav"},{"issue":"1","key":"1276_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12954-021-00539-8","volume":"18","author":"K Milaney","year":"2021","unstructured":"Milaney K, Passi J, Zaretsky L, Liu T, O\u2019Gorman CM, Hill L, et al. Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services. Harm Reduct J. 2021;18(1):92.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1276_CR47","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1186\/s12889-021-12104-w","volume":"21","author":"C Russell","year":"2021","unstructured":"Russell C, Ali F, Nafeh F, LeBlanc S, Imtiaz S, Elton-Marshall T, et al. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in ontario, Canada. BMC Public Health. 2021;21(1):2021.","journal-title":"BMC Public Health"},{"key":"1276_CR48","volume-title":"2024\/25\u20132026\/27 service plan","author":"BC Ministry of Mental Health and Addictions","year":"2024","unstructured":"BC Ministry of Mental Health and Addictions. 2024\/25\u20132026\/27 service plan. Victoria, BC: BC Ministry of Mental Health and Addictions; 2024."},{"key":"1276_CR49","volume-title":"Introduces new prescribed safer supply policy, a Canadian first [press release]","author":"B.C","year":"2021","unstructured":"B.C. Introduces new prescribed safer supply policy, a Canadian first [press release]. Victoria, BC: BC Ministry of Mental Health and Addictions; 2021."},{"key":"1276_CR50","unstructured":"Canadian Mental Health Association British Columbia (CMHA BC). BC Budget 2024: Sustained investments in mental health and substance use care, with key opportunities for improvement 2024. Available from: https:\/\/bc.cmha.ca\/news\/bc-budget-2024-mhsu\/"},{"key":"1276_CR51","volume-title":"Drug decriminalization policy literature review: models, implementation and outcomes","author":"A Unlu","year":"2020","unstructured":"Unlu A, Tammi T, Hakkarainen P. Drug decriminalization policy literature review: models, implementation and outcomes. Helsinki: Finnish Institute for Health and Welfare; 2020."},{"key":"1276_CR52","volume-title":"Health systems adaptations to support drug decriminalization","author":"V Haldane","year":"2023","unstructured":"Haldane V, Umar I, Roerig M, Allin S. Health systems adaptations to support drug decriminalization. Toronto, ON: North American Observatory on Health Systems and Policies; 2023."},{"key":"1276_CR53","volume-title":"Canadians\u2019 knowledge and attitudes around drug decriminalization: results from a public opinion research survey","author":"Health Canada","year":"2023","unstructured":"Health Canada. Canadians\u2019 knowledge and attitudes around drug decriminalization: results from a public opinion research survey. Ottawa, ON: Health Canada; 2023."},{"key":"1276_CR54","unstructured":"CBC News. B.C. suspends harm-reduction vending machines pending review2024. Available from: https:\/\/www.cbc.ca\/news\/canada\/british-columbia\/harm-reduction-vending-machines-suspended-1.7321345"},{"issue":"1","key":"1276_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-023-00747-4","volume":"20","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Cardamone NC, Loscalzo E, French R, Lovelace C, Mowenn WK, et al. There\u2019s absolutely no downside to this, I mean, except community opposition: A qualitative study of the acceptability of vending machines for harm reduction. Harm Reduct J. 2023;20(1):25.","journal-title":"Harm Reduct J"},{"key":"1276_CR56","unstructured":"Restricting Public Consumption of Illegal Substances Act, Legislative Assembly of British Columbia, 4th session, 42nd Parliament Sess. (2023)."},{"issue":"1","key":"1276_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12961-024-01150-6","volume":"22","author":"F Ali","year":"2024","unstructured":"Ali F, Law J, Russell C, Crepault JF, Goulao JC, Lock K, et al. Navigating the nexus between British columbia\u2019s public consumption and decriminalization policies of illegal drugs. Health Res Policy Syst. 2024;22(1):60.","journal-title":"Health Res Policy Syst"},{"key":"1276_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1747-597X-6-4","volume":"6","author":"K DeBeck","year":"2011","unstructured":"DeBeck K, Buxton J, Kerr T, Qi J, Montaner J, Wood E. Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. Subst Abuse Treat Prev Policy. 2011;6:4.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1276_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12954-023-00865-z","volume":"20","author":"KE Schneider","year":"2023","unstructured":"Schneider KE, Urquhart GJ, Rouhani S, Allen ST, Morris M, Sherman SG. High willingness to use overdose prevention sites among suburban people who use drugs who do not inject. Harm Reduct J. 2023;20(1):138.","journal-title":"Harm Reduct J"},{"key":"1276_CR60","volume-title":"Illicit drug toxicity Deaths - Knowledge update: mode of consumption","author":"BC Coroners Service","year":"2022","unstructured":"BC Coroners Service. Illicit drug toxicity Deaths - Knowledge update: mode of consumption. Victoria, BC: BC Coroners Service; 2022."},{"issue":"1\u20133","key":"1276_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugalcdep.2011.06.015","volume":"120","author":"K Debeck","year":"2012","unstructured":"Debeck K, Wood E, Qi J, Fu E, McArthur D, Montaner J, et al. Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder. Drug Alcohol Depend. 2012;120(1\u20133):28\u201334.","journal-title":"Drug Alcohol Depend"},{"key":"1276_CR62","doi-asserted-by":"crossref","unstructured":"Davis S, Wallace B, Van Roode T, Hore D. Substance use stigma and community drug checking: A qualitative study examining barriers and possible responses. Int J Environ Res Public Health. 2022;19(23).","DOI":"10.3390\/ijerph192315978"},{"key":"1276_CR63","doi-asserted-by":"crossref","unstructured":"Scher BD, Neufeld SD, Butler A, Bonn M, Zakimi N, Farrell J et al. Criminalization causes the stigma: perspectives from people who use drugs. Contemp Drug Probl. 2023;50(3).","DOI":"10.1177\/00914509231179226"},{"key":"1276_CR64","doi-asserted-by":"publisher","first-page":"104478","DOI":"10.1016\/j.drugpo.2024.104478","volume":"129","author":"L Michaud","year":"2024","unstructured":"Michaud L, McDermid J, Bailey A, Singh Kelsall T. Decriminalization or Police mission creep? Critical appraisal of law enforcement involvement in British columbia, canada\u2019s decriminalization framework. Int J Drug Policy. 2024;129:104478.","journal-title":"Int J Drug Policy"},{"key":"1276_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugpo.2017.03.014","volume":"45","author":"TC Wild","year":"2017","unstructured":"Wild TC, Pauly B, Belle-Isle L, Cavalieri W, Elliott R, Strike C, et al. Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000\u20132015. Int J Drug Policy. 2017;45:9\u201317.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1276_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12954-022-00655-z","volume":"19","author":"GH Yoon","year":"2022","unstructured":"Yoon GH, Levengood TW, Davoust MJ, Ogden SN, Kral AH, Cahill SR, et al. Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis. Harm Reduct J. 2022;19(1):73.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1276_CR67","doi-asserted-by":"publisher","first-page":"e2146980","DOI":"10.1001\/jamanetworkopen.2021.46980","volume":"5","author":"S Aronowitz","year":"2022","unstructured":"Aronowitz S, Meisel ZF. Addressing stigma to provide quality care to people who use drugs. JAMA Netw Open. 2022;5(2):e2146980.","journal-title":"JAMA Netw Open"},{"key":"1276_CR68","volume-title":"Interventions to reduce stigma among health care providers working with substance users","author":"HIV Ontario","year":"2018","unstructured":"Ontario HIV, Treatment Network. Interventions to reduce stigma among health care providers working with substance users. Ontario HIV Treatment Network: Toronto, ON; 2018."},{"key":"1276_CR69","doi-asserted-by":"publisher","first-page":"100196","DOI":"10.1016\/j.dadr.2023.100196","volume":"9","author":"A Cazalis","year":"2023","unstructured":"Cazalis A, Lambert L, Auriacombe M. Stigmatization of people with addiction by health professionals: current knowledge. A scoping review. Drug Alcohol Depend Rep. 2023;9:100196.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"3","key":"1276_CR70","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/17456916211017860","volume":"17","author":"EA Waters","year":"2022","unstructured":"Waters EA, Kiviniemi MT, Hay JL, Orom H. Dismissing don\u2019t know responses to perceived risk survey items threatens the validity of theoretical and empirical Behavior-Change research. Perspect Psychol Sci. 2022;17(3):841\u201351.","journal-title":"Perspect Psychol Sci"},{"issue":"4","key":"1276_CR71","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1504\/IJBHR.2011.043414","volume":"2","author":"R Rosenman","year":"2011","unstructured":"Rosenman R, Tennekoon V, Hill LG. Measuring bias in self-reported data. Int J Behav Healthc Res. 2011;2(4):320\u201332.","journal-title":"Int J Behav Healthc Res"},{"issue":"1","key":"1276_CR72","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1186\/s12889-024-20336-9","volume":"24","author":"C Russell","year":"2024","unstructured":"Russell C, Ali F, Imtiaz S, Butler A, Greer A, Rehm J, et al. The decriminalization of illicit drugs in British columbia: a National evaluation protocol. BMC Public Health. 2024;24(1):2879.","journal-title":"BMC Public Health"},{"key":"1276_CR73","doi-asserted-by":"crossref","unstructured":"Russell C, Law J, Hodgson K, MacKinnon L, Shahin R, Crichlow F et al. Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia\u2019s drug decriminalization policy: Insights from a provincial survey. Can J Public Health. 2025.","DOI":"10.17269\/s41997-025-01060-2"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01276-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01276-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01276-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:44:02Z","timestamp":1757259842000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01276-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01276-y","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Centre for Addiction and Mental Health (CAMH) Research Ethics Board (#2023\/169). Informed consent was obtained from all individual participants in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"122"}}